TAVI: is it cost effective?
Posted by Paul Scuffham
on 1 June 2015
Paul Scuffham and Cindy Mervin are undertaking an economic evaluation of the treatment and follow-up costs to the health system for Transcatheter Aortic Valve replacement in Australia.
)
Author: Paul Scuffham
About: Paul Scuffham, the Foundation Professor of Health Economics at Griffith University Australia, graduated with a PhD (Economics) from the University of Otago. He has extensive experience in economic evaluation of health services and interventions such as medical devices and pharmaceuticals.
| Tags: Cardiovascular Disease |
Post comment